Immitra Bio Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Early Stage VC
- Latest Deal Amount
-
$2.97M
- Investors
-
11
Immitra Bio General Information
Description
Developer of an in vivo gene-editing platform designed to enable one-time curative therapies for genetic diseases. The company offers mutation-agnostic gene-editing technology and a digital target-identification platform that avoids ex vivo cell manipulation, patient conditioning, stem cell transplantation, and personalized treatment approaches, enabling healthcare providers and patients with genetic disorders to access streamlined gene-editing therapies.
Contact Information
Website
www.immitrabio.comCorporate Office
- Route de la Galaise 34
- 1228 Plan-les-Ouates
- Geneva
- Switzerland
Corporate Office
- Route de la Galaise 34
- 1228 Plan-les-Ouates
- Geneva
- Switzerland
Immitra Bio Timeline
Immitra Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Early Stage VC | 21-Jul-2026 | $2.97M | Completed | Pre-Clinical Trials | ||
| 5. Grant | 28-Oct-2025 | Completed | Product Development | |||
| 4. Debt - General | 07-Mar-2025 | Completed | Product Development | |||
| 3. Grant | 01-Mar-2022 | Completed | Product Development | |||
| 2. Grant | 01-Mar-2021 | $167K | Completed | Product Development | ||
| 1. Accelerator/Incubator | Completed | Product Development |
Immitra Bio Comparisons
Industry
Financing
Details
Immitra Bio Competitors (5)
One of Immitra Bio’s 5 competitors is CRISPR Therapeutics, a Formerly VC-backed company based in Zug, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CRISPR Therapeutics | Formerly VC-backed | Zug, Switzerland | ||||
| Editas Medicine | Formerly VC-backed | Cambridge, MA | ||||
| Vertex Pharmaceuticals | Formerly VC-backed | Boston, MA | ||||
| Beam Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Genetix Biotherapeutics | Private Equity-Backed | Somerville, MA |
Immitra Bio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Immitra Bio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Immitra Bio Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| another.vc | Venture Capital | Minority | ||
| BackBone Ventures | Venture Capital | Minority | ||
| ETH Zürich Foundation | Limited Partner | Minority | ||
| Fongit | Accelerator/Incubator | Minority | ||
| Kickfund | Venture Capital | Minority |
Immitra Bio FAQs
-
When was Immitra Bio founded?
Immitra Bio was founded in 2021.
-
Where is Immitra Bio headquartered?
Immitra Bio is headquartered in Geneva, Switzerland.
-
What is the size of Immitra Bio?
Immitra Bio has 5 total employees.
-
What industry is Immitra Bio in?
Immitra Bio’s primary industry is Drug Discovery.
-
Is Immitra Bio a private or public company?
Immitra Bio is a Private company.
-
What is Immitra Bio’s current revenue?
The current revenue for Immitra Bio is .
-
How much funding has Immitra Bio raised over time?
Immitra Bio has raised $3.08M.
-
Who are Immitra Bio’s investors?
another.vc, BackBone Ventures, ETH Zürich Foundation, Fongit, and Kickfund are 5 of 11 investors who have invested in Immitra Bio.
-
Who are Immitra Bio’s competitors?
CRISPR Therapeutics, Editas Medicine, Vertex Pharmaceuticals, Beam Therapeutics, and Genetix Biotherapeutics are competitors of Immitra Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
